GoingToMeet

The Pharmaceutical industry is experiencing declining productivity and success rates. To meet the ever advancing quality standards in this increasingly globalised industry, companies are re-evaluating their drug development strategies in order to reduce attrition rates at later stages. Various research and decision making tools, such as enabling technologies and biomarkers are being utilized at different stages of the development process in order to revitalise efficiency and yield, and to bring greater quantities of improved drugs to market faster.

The Drug Development Congress, presented by Oxford Global Conferences, provides a first class educational and networking opportunity for over 100 attendees to gain knowledge and insights into the Drug Development process.

The event explores core topics in early development, such as Toxicology & Safety Biomarkers, regulatory and risk assessment issues, Pharmacology and its increased importance in development, personalised and translational therapeutics, and outsourcing and partnerships in global drug development

Do not miss out on this opportunity to hear cutting edge case study presentations focusing on Drug Development in different therapeutic areas and from both big and emerging Pharma.